HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017
May 01 2017 - 4:01PM
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of
instruments, reagents, and services for molecular profiling
applications, today announced that the Company will release 2017
first quarter results after market close on Monday, May 15, 2017.
Company management will host an investment-community conference
call beginning at 4:30pm Eastern Time on Monday, May 15 to discuss
these results and answer questions.
Individuals interested in listening to the conference call may
do so by dialing (866) 394-4225 for domestic callers, or (678)
509-7535 for international callers (conference ID: 13619211), or
from the webcast on the “Investors” section of the Company’s
website at: www.htgmolecular.com. The webcast will be available on
the Company’s website for 90 days following the completion of the
call.
About HTG:
Headquartered in Tucson, Arizona, the mission of HTG Molecular
Diagnostics (HTG) is to empower precision medicine at the local
level. In 2013 the company commercialized its first instrument
platform and a portfolio of RNA assays that leveraged HTG's
original proprietary nuclease protection chemistry. Continuous
improvement led to the 2014 launch of the company’s HTG EdgeSeq
product line, which automates sample and targeted library
preparation for next-generation sequencing. Additional information
is available at www.htgmolecular.com.
Contact:
Westwicke Partners
Jamar Ismail
Phone: (415) 513-1282
Email: jamar.ismail@westwicke.com
TJ Johnson
President / CEO
HTG Molecular Diagnostics
Phone: (520) 547-2827 x130
Email: tjjohnson@htgmolecular.com
HTG Molecular Diagnostics (NASDAQ:HTGM)
Historical Stock Chart
From Aug 2024 to Sep 2024
HTG Molecular Diagnostics (NASDAQ:HTGM)
Historical Stock Chart
From Sep 2023 to Sep 2024